The Role of the 21-Gene Recurrence Score<sup>®</sup> Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
The management of patients with hormone receptor-positive breast cancer has changed dramatically with use of the 21-gene Recurrence Score<sup>®</sup> (RS) Assay. While the utility of the assay was initially demonstrated among node-negative patients, recent studies have also demonstrated...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-03-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/29/3/163 |